Methimazole-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and lupus-like syndrome with a cutaneous feature of vesiculo-bullous systemic lupus erythematosus [1]

Thong H.-Y.CHIA-YU CHUHSIEN-CHING CHIU2019-12-052019-12-0520020001-5555https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036022549&doi=10.1080%2f00015550260132523&partnerID=40&md5=3a46a0adf7612523a6a04df892be1b3ahttps://scholars.lib.ntu.edu.tw/handle/123456789/435123[SDGs]SDG3antithyroid agent; carbimazole; hydralazine; isoniazid; methylprednisolone; neutrophil cytoplasmic antibody; phenytoin; procainamide; propranolol; propylthiouracil; thiamazole; thyrotropin; antithyroid agent; neutrophil cytoplasmic antibody; thiamazole; adult; antibody detection; bullous skin disease; case report; clinical medicine; disease course; female; histopathology; human; human tissue; hyperthyroidism; immunofluorescence; letter; lung biopsy; plasmapheresis; priority journal; skin biopsy; steroid therapy; systemic lupus erythematosus; thyroid function; vasculitis; adolescent; blood; bullous skin disease; chemically induced disorder; fluorescent antibody technique; Graves disease; pathology; skin lupus erythematosus; treatment outcome; vasculitis; Adolescent; Antibodies, Antineutrophil Cytoplasmic; Antithyroid Agents; Case Report; Female; Fluorescent Antibody Technique, Indirect; Graves' Disease; Human; Lupus Erythematosus, Cutaneous; Methimazole; Skin Diseases, Vesiculobullous; Treatment Outcome; Vasculitis; Adolescent; Female; Fluorescent Antibody Technique, Indirect; Graves Disease; Humans; Treatment OutcomeMethimazole-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and lupus-like syndrome with a cutaneous feature of vesiculo-bullous systemic lupus erythematosus [1]letter10.1080/00015550260132523123537142-s2.0-0036022549